pcb Search Results


94
LGC Standards pcb 153
Pcb 153, supplied by LGC Standards, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcb/Plastic+shipping+container+for+single+CER+01%2FCER+05+bottle/pm42353851-51-0-5
Average 94 stars, based on 1 article reviews
pcb 153 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Biosynth Carbosynth charybdotoxin chtx
IBTX and <t>ChTX</t> pharmacology. A, Application of the BK channel-blocking peptide IbTX to oocytes expressing hSlo or hSlo + hSloβ revealed that coexpression with the hSloβ subunit resulted in a nearly 10-fold decrease in the sensitivity to IbTX blockade;n = 5–10 oocytes/IbTX concentration. Maximal effect was defined as the effect produced by incubation in 100–250 nm IbTX; maximal levels of suppression did not differ significantly between hSlo and hSlo + hSloβ. B, Application of the peptidyl blocker ChTX did not reveal a significantly different profile of blockade forhSlo and hSlo + hSloβ. Maximal effect was defined as the response to 250–500 nmChTX, and maximal levels of effect did not differ betweenhSlo and hSlo + hSloβ.
Charybdotoxin Chtx, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcb/Charybdotoxin/pmc06579031-76-3-5
Average 90 stars, based on 1 article reviews
charybdotoxin chtx - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

92
Biosynth Carbosynth snx
IBTX and <t>ChTX</t> pharmacology. A, Application of the BK channel-blocking peptide IbTX to oocytes expressing hSlo or hSlo + hSloβ revealed that coexpression with the hSloβ subunit resulted in a nearly 10-fold decrease in the sensitivity to IbTX blockade;n = 5–10 oocytes/IbTX concentration. Maximal effect was defined as the effect produced by incubation in 100–250 nm IbTX; maximal levels of suppression did not differ significantly between hSlo and hSlo + hSloβ. B, Application of the peptidyl blocker ChTX did not reveal a significantly different profile of blockade forhSlo and hSlo + hSloβ. Maximal effect was defined as the response to 250–500 nmChTX, and maximal levels of effect did not differ betweenhSlo and hSlo + hSloβ.
Snx, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcb/SNX-482/pmc02872162-124-29-33
Average 92 stars, based on 1 article reviews
snx - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

91
LGC Standards mcf 10a cells
IBTX and <t>ChTX</t> pharmacology. A, Application of the BK channel-blocking peptide IbTX to oocytes expressing hSlo or hSlo + hSloβ revealed that coexpression with the hSloβ subunit resulted in a nearly 10-fold decrease in the sensitivity to IbTX blockade;n = 5–10 oocytes/IbTX concentration. Maximal effect was defined as the effect produced by incubation in 100–250 nm IbTX; maximal levels of suppression did not differ significantly between hSlo and hSlo + hSloβ. B, Application of the peptidyl blocker ChTX did not reveal a significantly different profile of blockade forhSlo and hSlo + hSloβ. Maximal effect was defined as the response to 250–500 nmChTX, and maximal levels of effect did not differ betweenhSlo and hSlo + hSloβ.
Mcf 10a Cells, supplied by LGC Standards, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcb/PCB+iso-Octane/pmc04848832-82-0-5
Average 91 stars, based on 1 article reviews
mcf 10a cells - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

92
Biosynth Carbosynth l gsmtx4
IBTX and <t>ChTX</t> pharmacology. A, Application of the BK channel-blocking peptide IbTX to oocytes expressing hSlo or hSlo + hSloβ revealed that coexpression with the hSloβ subunit resulted in a nearly 10-fold decrease in the sensitivity to IbTX blockade;n = 5–10 oocytes/IbTX concentration. Maximal effect was defined as the effect produced by incubation in 100–250 nm IbTX; maximal levels of suppression did not differ significantly between hSlo and hSlo + hSloβ. B, Application of the peptidyl blocker ChTX did not reveal a significantly different profile of blockade forhSlo and hSlo + hSloβ. Maximal effect was defined as the response to 250–500 nmChTX, and maximal levels of effect did not differ betweenhSlo and hSlo + hSloβ.
L Gsmtx4, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcb/GsMTx-4/10__1523_slash_jneurosci__3011___15__2016-167-14-16
Average 92 stars, based on 1 article reviews
l gsmtx4 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

94
Proteintech pyruvate carboxylase
Figure 6: GAPDHS knockdown leads to decreased glycolysis and an increase in <t>pyruvate</t> <t>carboxylase</t> activity with accumulation of downstream malate, fumarate, and aspartate. A,B) UT10 melanoma cells with GAPDHS knockdown (shA, shB), overexpression (GAPDHS), and corresponding control vectors (shSCR or pLOC) were cultured ex vivo and the relative abundance of metabolites in glycolysis (A) and the TCA cycle (B) were normalized to TIC. Each sample was then normalized to relative abundance of its corresponding control vector. Samples were run in triplicate. C,D) UT10 melanoma cells were cultured for 1 hour with [U-13C]glucose as described in the methods. M+3 fractional enrichment was plotted for each metabolite of interest for GAPDHS knockdown (shA and shB) (C) and GAPDHS overexpression (GAPDHS) cells (D). E) Pyruvate carboxylase activity is shown as measured by the ratio of m+3 citrate to m+3 pyruvate in the indicated samples. F) Relative abundance of aspartate in the indicated samples. G) Fractional enrichment of aspartate labeled with m+2 or m+3 in samples from (C) and (D). H-J) Relative abundance of malate (H), fumarate (I), and aspartate (J) in control and GAPDHS
Pyruvate Carboxylase, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcb/Pyruvate+Carboxylase+Antibody/pm35149585-130-28-31
Average 94 stars, based on 1 article reviews
pyruvate carboxylase - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology anti pyruvate carboxylase
Figure 6: GAPDHS knockdown leads to decreased glycolysis and an increase in <t>pyruvate</t> <t>carboxylase</t> activity with accumulation of downstream malate, fumarate, and aspartate. A,B) UT10 melanoma cells with GAPDHS knockdown (shA, shB), overexpression (GAPDHS), and corresponding control vectors (shSCR or pLOC) were cultured ex vivo and the relative abundance of metabolites in glycolysis (A) and the TCA cycle (B) were normalized to TIC. Each sample was then normalized to relative abundance of its corresponding control vector. Samples were run in triplicate. C,D) UT10 melanoma cells were cultured for 1 hour with [U-13C]glucose as described in the methods. M+3 fractional enrichment was plotted for each metabolite of interest for GAPDHS knockdown (shA and shB) (C) and GAPDHS overexpression (GAPDHS) cells (D). E) Pyruvate carboxylase activity is shown as measured by the ratio of m+3 citrate to m+3 pyruvate in the indicated samples. F) Relative abundance of aspartate in the indicated samples. G) Fractional enrichment of aspartate labeled with m+2 or m+3 in samples from (C) and (D). H-J) Relative abundance of malate (H), fumarate (I), and aspartate (J) in control and GAPDHS
Anti Pyruvate Carboxylase, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcb/PCB+Antibody/pmc10423811-42-26-29
Average 93 stars, based on 1 article reviews
anti pyruvate carboxylase - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
National Institute of Standards and Technology pcb congeners
Figure 6: GAPDHS knockdown leads to decreased glycolysis and an increase in <t>pyruvate</t> <t>carboxylase</t> activity with accumulation of downstream malate, fumarate, and aspartate. A,B) UT10 melanoma cells with GAPDHS knockdown (shA, shB), overexpression (GAPDHS), and corresponding control vectors (shSCR or pLOC) were cultured ex vivo and the relative abundance of metabolites in glycolysis (A) and the TCA cycle (B) were normalized to TIC. Each sample was then normalized to relative abundance of its corresponding control vector. Samples were run in triplicate. C,D) UT10 melanoma cells were cultured for 1 hour with [U-13C]glucose as described in the methods. M+3 fractional enrichment was plotted for each metabolite of interest for GAPDHS knockdown (shA and shB) (C) and GAPDHS overexpression (GAPDHS) cells (D). E) Pyruvate carboxylase activity is shown as measured by the ratio of m+3 citrate to m+3 pyruvate in the indicated samples. F) Relative abundance of aspartate in the indicated samples. G) Fractional enrichment of aspartate labeled with m+2 or m+3 in samples from (C) and (D). H-J) Relative abundance of malate (H), fumarate (I), and aspartate (J) in control and GAPDHS
Pcb Congeners, supplied by National Institute of Standards and Technology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcb/PCB+Congeners+in+iso-Octane/pm17099278-32-6-11
Average 92 stars, based on 1 article reviews
pcb congeners - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

94
LGC Standards pcb 118
Figure 6: GAPDHS knockdown leads to decreased glycolysis and an increase in <t>pyruvate</t> <t>carboxylase</t> activity with accumulation of downstream malate, fumarate, and aspartate. A,B) UT10 melanoma cells with GAPDHS knockdown (shA, shB), overexpression (GAPDHS), and corresponding control vectors (shSCR or pLOC) were cultured ex vivo and the relative abundance of metabolites in glycolysis (A) and the TCA cycle (B) were normalized to TIC. Each sample was then normalized to relative abundance of its corresponding control vector. Samples were run in triplicate. C,D) UT10 melanoma cells were cultured for 1 hour with [U-13C]glucose as described in the methods. M+3 fractional enrichment was plotted for each metabolite of interest for GAPDHS knockdown (shA and shB) (C) and GAPDHS overexpression (GAPDHS) cells (D). E) Pyruvate carboxylase activity is shown as measured by the ratio of m+3 citrate to m+3 pyruvate in the indicated samples. F) Relative abundance of aspartate in the indicated samples. G) Fractional enrichment of aspartate labeled with m+2 or m+3 in samples from (C) and (D). H-J) Relative abundance of malate (H), fumarate (I), and aspartate (J) in control and GAPDHS
Pcb 118, supplied by LGC Standards, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcb/PCB+No%2E+118/pm41770396-86-82-97
Average 94 stars, based on 1 article reviews
pcb 118 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
LGC Standards pcb 180
Figure 6: GAPDHS knockdown leads to decreased glycolysis and an increase in <t>pyruvate</t> <t>carboxylase</t> activity with accumulation of downstream malate, fumarate, and aspartate. A,B) UT10 melanoma cells with GAPDHS knockdown (shA, shB), overexpression (GAPDHS), and corresponding control vectors (shSCR or pLOC) were cultured ex vivo and the relative abundance of metabolites in glycolysis (A) and the TCA cycle (B) were normalized to TIC. Each sample was then normalized to relative abundance of its corresponding control vector. Samples were run in triplicate. C,D) UT10 melanoma cells were cultured for 1 hour with [U-13C]glucose as described in the methods. M+3 fractional enrichment was plotted for each metabolite of interest for GAPDHS knockdown (shA and shB) (C) and GAPDHS overexpression (GAPDHS) cells (D). E) Pyruvate carboxylase activity is shown as measured by the ratio of m+3 citrate to m+3 pyruvate in the indicated samples. F) Relative abundance of aspartate in the indicated samples. G) Fractional enrichment of aspartate labeled with m+2 or m+3 in samples from (C) and (D). H-J) Relative abundance of malate (H), fumarate (I), and aspartate (J) in control and GAPDHS
Pcb 180, supplied by LGC Standards, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcb/PCB+No%2E+180/pm41770396-86-90-97
Average 94 stars, based on 1 article reviews
pcb 180 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Proteintech anti pc
Figure 6: GAPDHS knockdown leads to decreased glycolysis and an increase in <t>pyruvate</t> <t>carboxylase</t> activity with accumulation of downstream malate, fumarate, and aspartate. A,B) UT10 melanoma cells with GAPDHS knockdown (shA, shB), overexpression (GAPDHS), and corresponding control vectors (shSCR or pLOC) were cultured ex vivo and the relative abundance of metabolites in glycolysis (A) and the TCA cycle (B) were normalized to TIC. Each sample was then normalized to relative abundance of its corresponding control vector. Samples were run in triplicate. C,D) UT10 melanoma cells were cultured for 1 hour with [U-13C]glucose as described in the methods. M+3 fractional enrichment was plotted for each metabolite of interest for GAPDHS knockdown (shA and shB) (C) and GAPDHS overexpression (GAPDHS) cells (D). E) Pyruvate carboxylase activity is shown as measured by the ratio of m+3 citrate to m+3 pyruvate in the indicated samples. F) Relative abundance of aspartate in the indicated samples. G) Fractional enrichment of aspartate labeled with m+2 or m+3 in samples from (C) and (D). H-J) Relative abundance of malate (H), fumarate (I), and aspartate (J) in control and GAPDHS
Anti Pc, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcb/PC+Antibody/pmc10027318-295-35-36
Average 93 stars, based on 1 article reviews
anti pc - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
LGC Standards pcb 101
Figure 6: GAPDHS knockdown leads to decreased glycolysis and an increase in <t>pyruvate</t> <t>carboxylase</t> activity with accumulation of downstream malate, fumarate, and aspartate. A,B) UT10 melanoma cells with GAPDHS knockdown (shA, shB), overexpression (GAPDHS), and corresponding control vectors (shSCR or pLOC) were cultured ex vivo and the relative abundance of metabolites in glycolysis (A) and the TCA cycle (B) were normalized to TIC. Each sample was then normalized to relative abundance of its corresponding control vector. Samples were run in triplicate. C,D) UT10 melanoma cells were cultured for 1 hour with [U-13C]glucose as described in the methods. M+3 fractional enrichment was plotted for each metabolite of interest for GAPDHS knockdown (shA and shB) (C) and GAPDHS overexpression (GAPDHS) cells (D). E) Pyruvate carboxylase activity is shown as measured by the ratio of m+3 citrate to m+3 pyruvate in the indicated samples. F) Relative abundance of aspartate in the indicated samples. G) Fractional enrichment of aspartate labeled with m+2 or m+3 in samples from (C) and (D). H-J) Relative abundance of malate (H), fumarate (I), and aspartate (J) in control and GAPDHS
Pcb 101, supplied by LGC Standards, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcb/PCB+No%2E+101/pm41770396-86-80-97
Average 94 stars, based on 1 article reviews
pcb 101 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


IBTX and ChTX pharmacology. A, Application of the BK channel-blocking peptide IbTX to oocytes expressing hSlo or hSlo + hSloβ revealed that coexpression with the hSloβ subunit resulted in a nearly 10-fold decrease in the sensitivity to IbTX blockade;n = 5–10 oocytes/IbTX concentration. Maximal effect was defined as the effect produced by incubation in 100–250 nm IbTX; maximal levels of suppression did not differ significantly between hSlo and hSlo + hSloβ. B, Application of the peptidyl blocker ChTX did not reveal a significantly different profile of blockade forhSlo and hSlo + hSloβ. Maximal effect was defined as the response to 250–500 nmChTX, and maximal levels of effect did not differ betweenhSlo and hSlo + hSloβ.

Journal: The Journal of Neuroscience

Article Title: Phenotypic Alteration of a Human BK ( hSlo ) Channel by hSloβ Subunit Coexpression: Changes in Blocker Sensitivity, Activation/Relaxation and Inactivation Kinetics, and Protein Kinase A Modulation

doi: 10.1523/JNEUROSCI.16-15-04543.1996

Figure Lengend Snippet: IBTX and ChTX pharmacology. A, Application of the BK channel-blocking peptide IbTX to oocytes expressing hSlo or hSlo + hSloβ revealed that coexpression with the hSloβ subunit resulted in a nearly 10-fold decrease in the sensitivity to IbTX blockade;n = 5–10 oocytes/IbTX concentration. Maximal effect was defined as the effect produced by incubation in 100–250 nm IbTX; maximal levels of suppression did not differ significantly between hSlo and hSlo + hSloβ. B, Application of the peptidyl blocker ChTX did not reveal a significantly different profile of blockade forhSlo and hSlo + hSloβ. Maximal effect was defined as the response to 250–500 nmChTX, and maximal levels of effect did not differ betweenhSlo and hSlo + hSloβ.

Article Snippet: Iberiotoxin (IbTX) and charybdotoxin (ChTX) (Peptides International, Louisville, KY) were prepared as aqueous stocks and diluted in MBS before use; tetrandrine (Aldrich, Milwaukee, WI) was prepared as a stock solution in dimethylformamide or dimethylsulfoxide (DMSO) and likewise diluted in the appropriate solution just before use.

Techniques: Blocking Assay, Expressing, Concentration Assay, Produced, Incubation

Figure 6: GAPDHS knockdown leads to decreased glycolysis and an increase in pyruvate carboxylase activity with accumulation of downstream malate, fumarate, and aspartate. A,B) UT10 melanoma cells with GAPDHS knockdown (shA, shB), overexpression (GAPDHS), and corresponding control vectors (shSCR or pLOC) were cultured ex vivo and the relative abundance of metabolites in glycolysis (A) and the TCA cycle (B) were normalized to TIC. Each sample was then normalized to relative abundance of its corresponding control vector. Samples were run in triplicate. C,D) UT10 melanoma cells were cultured for 1 hour with [U-13C]glucose as described in the methods. M+3 fractional enrichment was plotted for each metabolite of interest for GAPDHS knockdown (shA and shB) (C) and GAPDHS overexpression (GAPDHS) cells (D). E) Pyruvate carboxylase activity is shown as measured by the ratio of m+3 citrate to m+3 pyruvate in the indicated samples. F) Relative abundance of aspartate in the indicated samples. G) Fractional enrichment of aspartate labeled with m+2 or m+3 in samples from (C) and (D). H-J) Relative abundance of malate (H), fumarate (I), and aspartate (J) in control and GAPDHS

Journal: Cancer research

Article Title: A Short Isoform of Spermatogenic Enzyme GAPDHS Functions as a Metabolic Switch and Limits Metastasis in Melanoma.

doi: 10.1158/0008-5472.CAN-21-2062

Figure Lengend Snippet: Figure 6: GAPDHS knockdown leads to decreased glycolysis and an increase in pyruvate carboxylase activity with accumulation of downstream malate, fumarate, and aspartate. A,B) UT10 melanoma cells with GAPDHS knockdown (shA, shB), overexpression (GAPDHS), and corresponding control vectors (shSCR or pLOC) were cultured ex vivo and the relative abundance of metabolites in glycolysis (A) and the TCA cycle (B) were normalized to TIC. Each sample was then normalized to relative abundance of its corresponding control vector. Samples were run in triplicate. C,D) UT10 melanoma cells were cultured for 1 hour with [U-13C]glucose as described in the methods. M+3 fractional enrichment was plotted for each metabolite of interest for GAPDHS knockdown (shA and shB) (C) and GAPDHS overexpression (GAPDHS) cells (D). E) Pyruvate carboxylase activity is shown as measured by the ratio of m+3 citrate to m+3 pyruvate in the indicated samples. F) Relative abundance of aspartate in the indicated samples. G) Fractional enrichment of aspartate labeled with m+2 or m+3 in samples from (C) and (D). H-J) Relative abundance of malate (H), fumarate (I), and aspartate (J) in control and GAPDHS

Article Snippet: The following primary antibodies were used for western blot analysis: GAPDHS (sc-293335, Santa Cruz Biotechnology, 1:500), GAPDH (14C10, Cell Signaling Technology, 1:10,000), ACTIN (D6A8, Cell Signaling Technologies, 1:1000) PYRUVATE CARBOXYLASE (16588–1-AP, Proteintech, 1:1000).

Techniques: Knockdown, Activity Assay, Over Expression, Control, Cell Culture, Ex Vivo, Plasmid Preparation, Labeling